Lipoprotein(a)-activated immunity, insulin resistance and new-onset diabetes

Kaya A., Onat A., Yuksel H., Can G., Yuksel M., Ademoglu E.

POSTGRADUATE MEDICINE, cilt.129, sa.6, ss.611-618, 2017 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 129 Sayı: 6
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1080/00325481.2017.1342508
  • Dergi Adı: POSTGRADUATE MEDICINE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.611-618
  • Anahtar Kelimeler: Autoimmune activation, diabetes, type-2, impaired fasting glucose, insulin resistance, lipoprotein(a), CORONARY-ARTERY-DISEASE, AUTOIMMUNE ACTIVATION, LP(A) CONCENTRATIONS, CARDIOVASCULAR RISK, MELLITUS, GLUCOSE, WOMEN, MEN, APOLIPOPROTEIN, COMPLEXES
  • İstanbul Üniversitesi-Cerrahpaşa Adresli: Hayır

Özet

Objectives: Some evidence suggests that serum lipoprotein[Lp](a) may be inversely linked to type-2 diabetes. We aimed to determine in nondiabetic people the relationship of serum [Lp](a) with insulin resistance and new-onset diabetes (NOD).